As more tech companies lay off workers, job cuts at Twitter are poised to make more noiseByAnanya BhattacharyaUpdatedNovember 4, 2022
Pfizer plans to sell its covid vaccine at a 10,000% markup in 2023ByAnnalisa MerelliPublishedOctober 22, 2022
The US's estimate for uptake of the new covid booster was off by more than 90%ByAnnalisa MerelliPublishedOctober 11, 2022
Svante Pääbo, the 2022 Nobel laureate in medicine, helped humans understand their originsByAnanya BhattacharyaPublishedOctober 3, 2022
South Africa and India will make four vaccines without the help of rich western countriesByAnnalisa MerelliPublishedSeptember 1, 2022
240 million Americans will likely be eligible for omicron-specific vaccine boosters after Labor DayByAnnalisa MerelliPublishedAugust 24, 2022
How China beat US pharma giant Gilead in the race to create a covid antiviral pillByMary HuiPublishedJuly 6, 2022
A law professor’s big idea for combatting greedy drug company titans like Martin ShkreliByNoah BerlatskyPublishedSeptember 21, 2017
Quartz Daily Brief—Asia edition—Sweden’s stuck, Air France fumbles, US Fed meeting, rotten cometsByQuartzPublishedOctober 27, 2014
Quartz Daily Brief—Europe edition—Pfizer’s tax try, US probes Pimco, RBS floats Citizens, London supermarket mushroomsByRichard MacauleyPublishedSeptember 24, 2014
Do massive stock buybacks signal greed or stagnation? (Or both?)ByTim FernholzPublishedSeptember 22, 2014
